The announcement of a $500 million NIH project to develop a vaccine platform using outdated technology has divided experts, sparking concerns about the future of pandemic preparedness and funding priorities.
The U.S. Department of Health and Human Services is on a bold mission to develop a universal flu vaccine within four years, a project that could revolutionize how we combat influenza and prepare for future pandemics. Funded by $500 million, this initiative aims for FDA approval by 2029, with clinical trials starting soon. Experts weigh in on the challenges and potential of this ambitious project.
In an unprecedented move, U.S. Senators express deep concerns over the FDA's cancellation of a critical VRBPAC meeting, risking vaccine availability during the worst flu season in 15 years. The senators demand accountability and clarity from nominee Dr. Marty Makary.
The recent cancellation of a key FDA meeting on flu vaccine strains has raised alarms among health experts, who fear it could impact vaccine quality and availability. With flu season approaching, is the U.S. prepared to protect its citizens?
Rondi Bishop recounts the harrowing experience of her son Elliot's hospitalization during a severe flu season, highlighting the importance of vaccination amidst rising pediatric cases and complications.
This year's flu season is one of the worst in decades, and with critical FDA meetings canceled, experts warn of potential vaccine shortages and public health risks. Are we ready for the next pandemic?
New analyses from CDC networks highlight the effectiveness of the 2024-25 influenza vaccine in preventing illness among children and adults. Discover how vaccination impacts flu-related hospitalizations and outpatient visits.
This year's flu season is among the worst in decades, compounded by vaccine skepticism and canceled FDA meetings. Experts warn of dire consequences for public health and future vaccinations.
In a shocking move, the FDA has canceled a vital meeting on flu vaccine strains, raising concerns during one of the most severe flu seasons in over a decade. Expert Dr. Paul Offitt weighs in on the implications.
CDC was directed to stop promoting flu vaccines and shift focus to informed consent, raising concerns about vaccination rates. Learn how this decision could impact public health.
